2022 Q2 Form 10-Q Financial Statement

#000121390022048084 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $160.0K $60.00K
YoY Change
Gross Profit $53.00K $160.0K
YoY Change
Gross Profit Margin
Selling, General & Admin $422.6K $353.2K $253.4K
YoY Change 188.5% 900.79%
% of Gross Profit 797.42% 220.74%
Research & Development $4.800M $3.250M
YoY Change
% of Gross Profit 9056.6% 2031.25%
Depreciation & Amortization $3.325M $3.280M
YoY Change
% of Gross Profit 6273.58% 2050.0%
Operating Expenses $422.6K $353.2K $253.4K
YoY Change 188.48% 900.79%
Operating Profit -$422.6K -$353.2K
YoY Change 188.5%
Interest Expense $6.681M $17.93M $2.085M
YoY Change -290.64%
% of Operating Profit
Other Income/Expense, Net $0.00 $17.93M $0.00
YoY Change -100.0%
Pretax Income $6.258M $17.57M $1.832M
YoY Change -197.5% -49894.22%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $6.258M $17.57M $1.762M
YoY Change -197.5% -49897.04%
Net Earnings / Revenue
Basic Earnings Per Share -$3.70
Diluted Earnings Per Share $139.5K $391.8K $40.85K
COMMON SHARES
Basic Shares Outstanding 3.716M shares
Diluted Shares Outstanding 3.716M shares

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.127M $2.281M $2.570M
YoY Change -48.22%
Cash & Equivalents $2.127M $2.281M $2.570M
Short-Term Investments
Other Short-Term Assets $548.6K $686.3K $746.7K
YoY Change -46.21% 118.92%
Inventory
Prepaid Expenses $548.6K $746.7K
Receivables
Other Receivables
Total Short-Term Assets $2.684M $2.975M $3.325M
YoY Change -47.67% 849.14%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $345.5M $345.1M $345.0M
YoY Change 0.14%
Total Long-Term Assets $345.5M $345.1M $345.0M
YoY Change 0.14%
TOTAL ASSETS
Total Short-Term Assets $2.684M $2.975M $3.325M
Total Long-Term Assets $345.5M $345.1M $345.0M
Total Assets $348.2M $348.1M $348.4M
YoY Change -0.56% 110924.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.241K $5.180K $143.4K
YoY Change -99.64% -56.83%
Accrued Expenses $649.3K $517.7K $375.9K
YoY Change 43.42% 180.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $653.6K $522.9K $519.3K
YoY Change -63.82% 61.99%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $17.66M $23.90M $41.80M
YoY Change -54.2%
Total Long-Term Liabilities $17.66M $23.90M $41.80M
YoY Change -54.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $653.6K $522.9K $519.3K
Total Long-Term Liabilities $17.66M $23.90M $41.80M
Total Liabilities $18.32M $24.71M $42.32M
YoY Change -54.35% 7564.54%
SHAREHOLDERS EQUITY
Retained Earnings -$16.03M -$38.56M
YoY Change
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$16.03M $323.3M -$38.56M
YoY Change
Total Liabilities & Shareholders Equity $348.2M $348.1M $348.4M
YoY Change -0.56% 110924.36%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income $6.258M $17.57M $1.762M
YoY Change -197.5% -49897.04%
Depreciation, Depletion And Amortization $3.325M $3.280M
YoY Change
Cash From Operating Activities -$154.3K -$204.2K -$72.01K
YoY Change 474.56%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -85.00K -166.6K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -154.3K -204.2K -72.01K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 0.000 -85.00K -166.6K
Net Change In Cash -154.3K -289.2K -238.6K
YoY Change -98.93%
FREE CASH FLOW
Cash From Operating Activities -$154.3K -$204.2K -$72.01K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$154.3K -$204.2K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
RICE ACQUISITION CORP. II
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity File Number
EntityFileNumber
001-40503
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1580612
dei Entity Address Address Line1
EntityAddressAddressLine1
102 East Main Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Second Story  Carnegie
dei Entity Address City Or Town
EntityAddressCityOrTown
Pennsylvania
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
15106
dei City Area Code
CityAreaCode
(713)
dei Local Phone Number
LocalPhoneNumber
446-6259
dei Security12b Title
Security12bTitle
Class A ordinary shares, par value $.0001 per share
dei Trading Symbol
TradingSymbol
RONI
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 us-gaap Cash
Cash
2126928 usd
CY2021Q4 us-gaap Cash
Cash
2570409 usd
CY2022Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
7960 usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
7960 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
548630 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
746720 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
2683518 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
3325089 usd
CY2022Q2 us-gaap Assets Held In Trust
AssetsHeldInTrust
345513074 usd
CY2021Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
345044341 usd
CY2022Q2 us-gaap Assets
Assets
348196592 usd
CY2021Q4 us-gaap Assets
Assets
348369430 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4241 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
143405 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
649324 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
375918 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
653565 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
519323 usd
CY2022Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
11721500 usd
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
11721500 usd
CY2022Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
5940340 usd
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
30077750 usd
CY2022Q2 us-gaap Liabilities
Liabilities
18315405 usd
CY2021Q4 us-gaap Liabilities
Liabilities
42318573 usd
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
345387074 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
345000000 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q2 roni Common Stock Value1
CommonStockValue1
863 usd
CY2021Q4 roni Common Stock Value1
CommonStockValue1
863 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16032409 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38559114 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-16031546 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-38558251 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
525659 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
-390892 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-15505887 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-38949143 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
348196592 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
348369430 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
392630 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
146494 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
715813 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
181782 usd
CY2022Q2 roni General And Administrative Expenses Related Party
GeneralAndAdministrativeExpensesRelatedParty
30000 usd
roni General And Administrative Expenses Related Party
GeneralAndAdministrativeExpensesRelatedParty
60000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-422630 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-146494 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-775813 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-181782 usd
CY2022Q2 roni Change In Fair Value Of Derivative Warrant Liabilities
ChangeInFairValueOfDerivativeWarrantLiabilities
6242323 usd
CY2021Q2 roni Change In Fair Value Of Derivative Warrant Liabilities
ChangeInFairValueOfDerivativeWarrantLiabilities
-3505250 usd
roni Change In Fair Value Of Derivative Warrant Liabilities
ChangeInFairValueOfDerivativeWarrantLiabilities
24137410 usd
roni Change In Fair Value Of Derivative Warrant Liabilities
ChangeInFairValueOfDerivativeWarrantLiabilities
-3505250 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
438258 usd
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
945 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
468733 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
945 usd
CY2021Q2 roni Financing Costs
FinancingCosts
592641 usd
roni Financing Costs
FinancingCosts
592641 usd
CY2021Q2 roni Loss Upon Issuance Of Private Placement Warrants
LossUponIssuanceOfPrivatePlacementWarrants
2175000 usd
roni Loss Upon Issuance Of Private Placement Warrants
LossUponIssuanceOfPrivatePlacementWarrants
2175000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
6257951 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-6418440 usd
us-gaap Profit Loss
ProfitLoss
23830330 usd
us-gaap Profit Loss
ProfitLoss
-6453728 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
240690 usd
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-246863 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
916551 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-248220 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6017261 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6171577 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22913779 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6205508 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-38949143 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
17572379 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-21376764 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
6257951 usd
CY2022Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-387074 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-15505887 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1000 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-35288 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-9288 usd
CY2021Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-28785962 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-6418440 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-35213690 usd
us-gaap Profit Loss
ProfitLoss
23830330 usd
us-gaap Profit Loss
ProfitLoss
-6453728 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
26000 usd
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
9360 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-24137410 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3505250 usd
us-gaap Interest Income Other
InterestIncomeOther
468733 usd
us-gaap Interest Income Other
InterestIncomeOther
945 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2175000 usd
roni Offering Costs Associated With Warrants
OfferingCostsAssociatedWithWarrants
592641 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-198090 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1019935 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-54164 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1121776 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
273406 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
17732 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-358481 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26849 usd
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
345026000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-345026000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
326474038 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10900000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
85000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
6739299 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-85000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
330634739 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-443481 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-14418110 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2570409 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2126928 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-14418110 usd
roni Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
65577 usd
roni Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
435000 usd
roni Offering Costs Paid By Related Party Under Promissory Note
OfferingCostsPaidByRelatedPartyUnderPromissoryNote
157227 usd
roni Deferred Underwriting Commissions
DeferredUnderwritingCommissions
11721500 usd
CY2021Q2 roni Generating Gross Proceeds
GeneratingGrossProceeds
345000000 usd
CY2021Q2 us-gaap Other Ownership Interests Offering Costs
OtherOwnershipInterestsOfferingCosts
19100000 usd
CY2021Q2 roni Deferred Underwriting Commissions
DeferredUnderwritingCommissions
11700000 usd
CY2021Q2 us-gaap General Partners Offering Costs
GeneralPartnersOfferingCosts
593000 usd
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
345026000 usd
roni Maturity Of Money Market Funds Term
MaturityOfMoneyMarketFundsTerm
P185D
roni Percentage Of Fair Market Value
PercentageOfFairMarketValue
0.80 pure
CY2022Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10
CY2022Q2 us-gaap Assets Net
AssetsNet
5000001 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
100000 usd
CY2022Q2 roni Operating Bank Amount
OperatingBankAmount
2100000 usd
CY2022Q2 roni Working Capital Deficit
WorkingCapitalDeficit
2000000 usd
us-gaap Other Expenses
OtherExpenses
25000 usd
CY2022Q2 us-gaap Other Loans Payable
OtherLoansPayable
126000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of June 30, 2022 and December 31, 2021, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p>
CY2022Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
5000001 usd
CY2022Q2 us-gaap Shares Issued
SharesIssued
19525000 shares
CY2022Q2 roni Price Per Warrant
PricePerWarrant
1
CY2021Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
10000 usd
CY2022Q2 us-gaap Interest Costs Incurred
InterestCostsIncurred
30000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
60000 usd
roni Offering Costs Paid By Related Party Under Promissory Note
OfferingCostsPaidByRelatedPartyUnderPromissoryNote
usd
CY2021Q2 roni Initial Public Offering Description1
InitialPublicOfferingDescription1
the Company consummated its Initial Public Offering of 34,500,000 Units, which included the full exercise of the underwriters’ option to purchase an additional 4,500,000 Units to cover over-allotments, at $10.00 per Unit, generating gross proceeds of $345.0 million, and incurring offering costs of approximately $19.1 million, of which approximately $11.7 million and approximately $593,000 was for deferred underwriting commissions and offering costs allocated to the derivative warrant liabilities, respectively. Of the 34,500,000 Units sold, affiliates of Rice Investment Group had purchased 1,010,000 Units (the “Affiliated Units”) at the Initial Public Offering price. The underwriters did not receive any underwriting discounts or commissions on the 1,010,000 Affiliated Units.
CY2021Q1 roni Founder Shares And Sponsor Shares Description
FounderSharesAndSponsorSharesDescription
the Sponsor received 7,187,500 Class B Units of Opco for no consideration and purchased 7,187,600 of the Company’s Class B ordinary shares, par value $0.0001, 2,500 of the Company’s Class A ordinary shares and 100 Class A Units of Opco for aggregate consideration of $26,000. Of the aggregate consideration, Opco received $1,000 for the Class A Units and the Company received $25,000 for the Class A ordinary shares and the Class B ordinary shares. The Company then subscribed for 2,500 Class A Units of Opco for $25,000.
CY2021Q2 roni Founder Shares And Sponsor Shares Description
FounderSharesAndSponsorSharesDescription
the Sponsor forfeited 90,000 Class B Units of Opco, and 30,000 Class B Units of Opco were issued to each of the Company’s independent director nominees. The Sponsor transferred a corresponding number of shares of the Company’s Class B ordinary shares to the Company’s independent director nominees. In June 2021, the Company effected a dividend, and Opco effected a distribution, resulting in an aggregate of 8,625,000 Class B ordinary shares and 8,624,900 Class B Units of Opco outstanding, of which the Sponsor owned 8,535,000 of the Company’s Class B ordinary shares and 8,534,900 Class B Units of Opco.
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.20 pure
roni Sponsor Shares Description
SponsorSharesDescription
The Company refers to the 8,624,900 Class B ordinary shares and corresponding number of Class B Units of Opco (or the Class A Units of Opco into which such Class B Units will convert) collectively as the “Founder Units”. The Founder Units consist of Class B Units of Opco (and any Class A Units of Opco into which such Class B Units are converted) and a corresponding number of Class B ordinary shares, which together will be exchangeable for shares of the Company’s Class A ordinary shares after the time of the initial Business Combination on a one-for-one basis, subject to adjustment as provided herein. The Company refers to the 2,500 Class A ordinary shares and the 100 Class A Units of Opco and a corresponding number of shares of the Company’s non-economic Class B ordinary shares (which together will be exchangeable into Class A ordinary shares after the initial Business Combination on a one-for-one basis) collectively as the “Sponsor Units”.
roni Outstanding Shares Percentage
OutstandingSharesPercentage
0.20 pure
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
167000 usd
roni Working Capital Loans
WorkingCapitalLoans
1500000 usd
CY2022Q2 roni Additional Units Purchased
AdditionalUnitsPurchased
4500000 shares
roni Affiliated Units
AffiliatedUnits
1010000 shares
roni Underwriting Discount
UnderwritingDiscount
0.2
CY2022Q2 roni Aggregate Amount
AggregateAmount
6700000 usd
us-gaap Other Underwriting Expense
OtherUnderwritingExpense
11700000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
345000000 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
10260000 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
18525962 usd
roni Accretion On Class A Ordinary Shares Subject To Possible Redemption Amount
AccretionOnClassAOrdinarySharesSubjectToPossibleRedemptionAmount
28785962 usd
CY2021Q4 roni Class A Ordinary Shares Subject To Possible Redemption
ClassAOrdinarySharesSubjectToPossibleRedemption
345000000 usd
roni Increase In Redemption Value Of Class A Ordinary Shares Subject To Redemption
IncreaseInRedemptionValueOfClassAOrdinarySharesSubjectToRedemption
387074 usd
CY2022Q2 roni Class A Ordinary Shares Subject To Possible Redemption
ClassAOrdinarySharesSubjectToPossibleRedemption
345387074 usd
us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.20 pure
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 roni Exercise Price Per Share
ExercisePricePerShare
11.5
roni Expire Year
ExpireYear
P5Y
CY2022Q2 roni Percentage Of Exercise Price Of Warrants Adjusted
PercentageOfExercisePriceOfWarrantsAdjusted
1.15 pure
us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
0.01
roni Ordinary Shares Equals Or Exceeds Per Share
OrdinarySharesEqualsOrExceedsPerShare
10
CY2022Q2 us-gaap Increase Decrease In Fair Value Adjustments On Assets And Liabilities Carried At Fair Value Under Fair Value Option
IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
6200000 usd
us-gaap Increase Decrease In Fair Value Adjustments On Assets And Liabilities Carried At Fair Value Under Fair Value Option
IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
24100000 usd
CY2021Q2 us-gaap Increase Decrease In Fair Value Adjustments On Assets And Liabilities Carried At Fair Value Under Fair Value Option
IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
3500000 usd
us-gaap Increase Decrease In Fair Value Adjustments On Assets And Liabilities Carried At Fair Value Under Fair Value Option
IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
3500000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
11.5
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
11.5
CY2022Q2 roni Stock Pricein Dollars Per Share
StockPriceinDollarsPerShare
9.76
CY2021Q4 roni Stock Pricein Dollars Per Share
StockPriceinDollarsPerShare
10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.0759 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2182 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M14D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y5M15D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.03 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.013 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
17140250 usd
CY2022Q1 roni Change In Fair Value Of Derivatives Warrant Liabilities
ChangeInFairValueOfDerivativesWarrantLiabilities
10305950 usd
CY2022Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
6834300 usd
CY2022Q2 roni Change In Fair Value Of Derivatives Warrant Liabilities
ChangeInFairValueOfDerivativesWarrantLiabilities
3481460 usd
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
3352840 usd
roni Issuance Of Public And Private Warrants
IssuanceOfPublicAndPrivateWarrants
21160000 usd
roni Loss Upon Issuance Of Private Warrants
LossUponIssuanceOfPrivateWarrants
2175000 usd
roni Change In Fair Value Of Derivatives Warrant Liabilities
ChangeInFairValueOfDerivativesWarrantLiabilities
-3505250 usd
CY2021Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
26840250 usd
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
roni Offering Costs Associated With Warrants
OfferingCostsAssociatedWithWarrants
usd
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
roni Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
usd
roni Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
usd
CY2021Q2 roni General And Administrative Expenses Related Party
GeneralAndAdministrativeExpensesRelatedParty
usd
CY2022Q2 roni Financing Costs
FinancingCosts
usd
roni Financing Costs
FinancingCosts
usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
usd
roni Deferred Underwriting Commissions
DeferredUnderwritingCommissions
usd
CY2021Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001845437

Files In Submission

Name View Source Status
0001213900-22-048084-index-headers.html Edgar Link pending
0001213900-22-048084-index.html Edgar Link pending
0001213900-22-048084.txt Edgar Link pending
0001213900-22-048084-xbrl.zip Edgar Link pending
f10q0622ex31-1_riceacquis2.htm Edgar Link pending
f10q0622ex31-2_riceacquis2.htm Edgar Link pending
f10q0622ex32-1_riceacquis2.htm Edgar Link pending
f10q0622ex32-2_riceacquis2.htm Edgar Link pending
f10q0622_riceacquis2.htm Edgar Link pending
f10q0622_riceacquis2_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
roni-20220630.xsd Edgar Link pending
Show.js Edgar Link pending
roni-20220630_cal.xml Edgar Link unprocessable
roni-20220630_def.xml Edgar Link unprocessable
roni-20220630_pre.xml Edgar Link unprocessable
roni-20220630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable